Mark A. Hlatky

Mark Hlatky Stanford Health Policy

Mark A. Hlatky, MD

  • Professor, Health Policy
  • Professor, Medicine (Cardiovascular Medicine)
  • Professor, Epidemiology & Population Heath (by courtesy)

Encina Commons,
615 Crothers Way, Room 200,
Stanford, CA 94305-6006

(650) 723-6426 (voice)
(650) 725-6951 (fax)

Biography

Mark Hlatky is a Professor of Health Policy and a Professor of Medicine (Cardiovasular Medicine) at the Stanford University School of Medicine. His major interests are in outcomes research, evidence-based medicine, and cost-effectiveness analysis. He introduced data collection about economic and quality of life endpoints in several randomized trials, principally trials of therapies for cardiovascular disease.

Hlatky received his MD from the University of Pennsylvania, and, after residency at the University of Arizona, studied as a Robert Wood Johnson Clinical Scholar at the University of California, San Francisco. He trained in cardiology at Duke University Medical Center, and then joined the Duke faculty. He has been at the Stanford University School of Medicine since 1989.

publications

Working Papers
June 2009

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Author(s)
cover link A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
Working Papers
December 2000

Prediction of Risk for Patients with Unstable Angina

Author(s)
cover link Prediction of Risk for Patients with Unstable Angina
Working Papers
November 1999

Evaluation of Beta-Blockers, Calcium Antagonists, Nitrates, and Alternative Therapies for Stable Angina

Author(s)
cover link Evaluation of Beta-Blockers, Calcium Antagonists, Nitrates, and Alternative Therapies for Stable Angina

In The News

Elders Take a Selfie
News

Lower Doses of Statins Just as Effective in Older Adults Who Are at Greater Risk of Side Effects from the Cholesterol Drugs

New research shows that starting cholesterol lowering treatment with a low- to moderate-intensity statin was associated with a greater reduction of LDL levels among older patients than with younger ones.
cover link Lower Doses of Statins Just as Effective in Older Adults Who Are at Greater Risk of Side Effects from the Cholesterol Drugs
Elderly Asian woman with back pain.
News

Study Shows Vitamin D Does Not Reduce Statin-Associated Muscle Pain

Statin-associated muscle symptoms are common and may lead to discontinuation of indicated statin therapy. So cardiologist Mark Hlatky and colleagues conducted a randomized, placebo-controlled, double-blind clinical trial of vitamin D supplementation.
cover link Study Shows Vitamin D Does Not Reduce Statin-Associated Muscle Pain
An elderly man sits alone on a bench.
News

Older Men Who Live Alone at Greater Risk for Cardiovascular Disease

New research shows that older men who live alone are at greater risk of managing chronic conditions and medications —a social conundrum that could lead to higher levels of cardiovascular disease.
cover link Older Men Who Live Alone at Greater Risk for Cardiovascular Disease